Orasure Technologies (OSUR) Liabilities and Shareholders Equity (2010 - 2025)
Orasure Technologies' (OSUR) quarterly Liabilities and Shareholders Equity came in at $403.2 million in Q4 2025, down 15.95% year-on-year from $479.7 million in Q4 2024, and down 4.71% quarter-over-quarter from $423.1 million in Q3 2025.
Orasure Technologies (OSUR) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
Orasure Technologies has disclosed Liabilities and Shareholders Equity across 16 years of filings, most recently posting $403.2 million for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $403.2 million, down 15.95% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 7.92% YoY), and the FY2025 annual result was $403.2 million, down 15.95% from the prior year.
- Liabilities and Shareholders Equity came in at $403.2 million for Q4 2025 at Orasure Technologies, down from $423.1 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $482.8 million in Q4 2023 to a low of $403.2 million in Q4 2025.
- The 5-year median for Liabilities and Shareholders Equity is $457.1 million (2021), against an average of $452.0 million.
- Across the five-year window, Liabilities and Shareholders Equity soared 40.43% in 2021 and fell 15.95% in 2025, its largest moves.
- Orasure Technologies' Liabilities and Shareholders Equity stood at $461.0 million in 2021, then decreased by 3.65% to $444.2 million in 2022, then gained by 8.7% to $482.8 million in 2023, then fell by 0.66% to $479.7 million in 2024, then retreated by 15.95% to $403.2 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $403.2 million (Q4 2025), $423.1 million (Q3 2025), and $445.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 20.11 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 50.83 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 39.01 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 8.78 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.11 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 14.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 6.31 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 19.85 Bn |
| 10 | Orasure Technologies | 304.09 Mn | 104.81 Mn | - | 403.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 403.17 Mn |
| Sep 30, 2025 | 423.10 Mn |
| Jun 30, 2025 | 445.04 Mn |
| Mar 31, 2025 | 457.61 Mn |
| Dec 31, 2024 | 479.66 Mn |
| Sep 30, 2024 | 464.09 Mn |
| Jun 30, 2024 | 466.34 Mn |
| Mar 31, 2024 | 467.56 Mn |
| Dec 31, 2023 | 482.85 Mn |
| Sep 30, 2023 | 458.43 Mn |
| Jun 30, 2023 | 453.59 Mn |
| Mar 31, 2023 | 459.42 Mn |
| Dec 31, 2022 | 444.18 Mn |
| Sep 30, 2022 | 432.21 Mn |
| Jun 30, 2022 | 429.25 Mn |
| Mar 31, 2022 | 435.53 Mn |
| Dec 31, 2021 | 460.99 Mn |
| Sep 30, 2021 | 455.76 Mn |
| Jun 30, 2021 | 465.05 Mn |
| Mar 31, 2021 | 456.50 Mn |